Featured

[Special Report] Trademark filing and litigation trends 2024: Insights and opportunities

Robert Reading

Director, Corporate Strategy, Content at Clarivate

Biopharma
What a string of semaglutide biosimilars could mean for Mainland China
Academia and Government
Introducing the Clarivate Academic AI Platform
Academia and Government
November 23, 2016
Life Sciences and Healthcare
November 22, 2016
Intellectual Property
November 21, 2016
Academia and Government
November 18, 2016
Intellectual Property
November 17, 2016
Academia and Government
November 16, 2016
Intellectual Property
November 16, 2016
Life Sciences and Healthcare
November 16, 2016
Life Sciences and Healthcare
November 15, 2016
Academia and Government
November 14, 2016
Academia and Government
November 10, 2016